Literature DB >> 26895316

[Secondary retroperitoneal fibrosis in a 39-year-old man after rectal cancer].

A Jarosch1, M Tiller2, H Rohrbach3, T Leimbach2, W Schepp2.   

Abstract

A 39-year-old man had been treated for rectal cancer 6 years ago by lower anterior resection of the rectum and perioperative radiochemotherapy. Since then follow-up had been unremarkable but now the patient presented with unspecific lower abdominal pain. The cause of the pain was identified as paraneoplastic retroperitoneal fibrosis secondary to metachronous pulmonary metastases of the rectal cancer.

Entities:  

Keywords:  Abdominal pain; IgG4-related disease; Prednisolone; Retroperitoneal fibrosis, paraneoplastic; Retroperitoneal fibrosis, secondary

Mesh：

Year:  2016        PMID： 26895316     DOI： 10.1007/s00108-016-0025-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  14 in total

Review 1.  Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease.

Authors:  James R Stone
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

Review 2.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 3.  The spectrum of chronic periaortitis.

Authors:  D V Parums
Journal:  Histopathology       Date:  1990-05       Impact factor: 5.087

4.  Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial.

Authors:  Augusto Vaglio; Alessandra Palmisano; Federico Alberici; Umberto Maggiore; Stefania Ferretti; Rocco Cobelli; Francesco Ferrozzi; Domenico Corradi; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2011-07-04       Impact factor: 79.321

5.  Retroperitoneal fibrosis: role of imaging in diagnosis and follow-up.

Authors:  Rafael Oliveira Caiafa; Ana Sierra Vinuesa; Rafael Salvador Izquierdo; Blanca Paño Brufau; Juan Ramón Ayuso Colella; Carlos Nicolau Molina
Journal:  Radiographics       Date:  2013 Mar-Apr       Impact factor: 5.333

6.  Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease.

Authors:  Jan Laco; Miroslav Podhola; Kateřina Kamarádová; Ivo Novák; Daniel Dobeš; Miloš Broďák; Mária Hácová; Aleš Ryška
Journal:  Virchows Arch       Date:  2013-09-20       Impact factor: 4.064

7.  Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis.

Authors:  Nicolo Pipitone; Annibale Versari; Augusto Vaglio; Carlo Salvarani
Journal:  Clin Exp Rheumatol       Date:  2011-05-11       Impact factor: 4.473

8.  [Spontaneous healing of retroperitonea fibroasis after successful therapy of sigmoid carcinoma].

Authors:  E Templ; G Mostbeck; L Wagner; M Weissel
Journal:  Acta Med Austriaca       Date:  2000

Review 9.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

10.  Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

Authors:  E F H van Bommel; I Jansen; T R Hendriksz; A L H J Aarnoudse
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.